The importance of the gut microbiota in the promotion, development, and treatment outcomes of cancer with special regard to the gut-respiratory axis.


Journal

Otolaryngologia polska = The Polish otolaryngology
ISSN: 2300-8423
Titre abrégé: Otolaryngol Pol
Pays: Poland
ID NLM: 0404453

Informations de publication

Date de publication:
22 Aug 2022
Historique:
entrez: 22 2 2023
pubmed: 23 2 2023
medline: 25 2 2023
Statut: ppublish

Résumé

The role of oral and pharyngeal microbiota is important in the promotion and development of head and neck cancers, as discussed in detail in this publication. The object of this work is to gather scientific information on the importance of the gut- respiratory axis in the promotion, development, and treatment outcome of head and neck cancer (HNSCC). Scientific knowledge about the interaction of head and neck cancer tumor cells and gut microbiota is residual, so examples of the relationship between the gut microbiota and the promotion of development in cases of other malignancies are also discussed. The subject of this work is also to present the importance of the gut-respiratory axis in promotion, development, and its impact on treatment outcomes of head and neck cancers.

Identifiants

pubmed: 36805984
doi: 10.5604/01.3001.0015.9677
pii: 01.3001.0015.9677
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6-13

Auteurs

Piotr Nogal (P)

Department of Otolaryngology, Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland.

Małgorzata Wierzbicka (M)

Department of Otolaryngology, Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland.

Natalia Zagozda (N)

Department of Otolaryngology, Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland.

Joanna Jackowska (J)

Department of Otolaryngology, Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH